Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition

Title: Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition
Authors: da Hora, Cintia Carla; Pinkham, Kelsey; Carvalho, Litia; Zinter, Max; Tabet, Elie; Nakano, Ichiro; Tannous, Bakhos A.; Badr, Christian E.
Contributors: U.S. Department of Health & Human Services | NIH | National Cancer Institute; U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Source: Cell Death Discovery ; volume 5, issue 1 ; ISSN 2058-7716
Publisher Information: Springer Science and Business Media LLC
Publication Year: 2019
Description: Glioblastoma is an incurable and highly aggressive brain tumor. Understanding therapeutic resistance and survival mechanisms driving this tumor type is key to finding effective therapies. Smac mimetics (SM) emerged as attractive cancer therapeutics particularly for tumor populations that are highly resistant to conventional apoptosis-inducing therapies. We evaluated the therapeutic efficacy of SM on Glioma stem-like cells (GSCs) and showed that this family of compounds stimulates an adaptive response triggered by TNFα. Increased expression of TNFα results in a prolonged and sustained activation of NF-κB and STAT3 signaling thus activating several tumor cell resistance mechanisms in GSCs. We show that STAT3 activation is contingent on EZH2 activation and uncover a synergistic lethality between SM and EZH2 inhibitors. Therapeutic inhibition of EZH2 impaired the viability of SM-treated GSCs. Our study outlines the molecular underpinnings of SM resistance in glioblastoma and provides mechanistic insight to overcome this resistance and increase therapeutic efficacy.
Document Type: article in journal/newspaper
Language: English
DOI: 10.1038/s41420-019-0155-9
Availability: https://doi.org/10.1038/s41420-019-0155-9; https://www.nature.com/articles/s41420-019-0155-9.pdf; https://www.nature.com/articles/s41420-019-0155-9
Rights: https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0
Accession Number: edsbas.C8485897
Database: BASE